Description:

The relatively new and growing application of genetic testing and gene therapy within the realm of eye care has brought to the forefront numerous ethical and legal considerations.  In this course we will discuss ethical considerations relating to genetic testing, primarily data privacy and confidentiality. We will also look at several clinical scenarios that bring up ethical questions. We will speculate on future ethical dilemmas, as researchers are currently using CRISPR technology to develop new gene editing techniques.  Unfortunately, not all these ethical questions have clear answers. To help guide decision making, current recommendations by the American Academy of Ophthalmology's Task Force on Genetic Testing and the American Medical Association will be examined.  Lastly, we will cover current laws that regulate genetic discrimination in the United States.

Course Code:

AOA103-EJ

Speaker(s):

Rachelle Lin, O.D.
rachelle.lin@gmail.com

Credits:

1

AOA Expiration Date:

3/30/2024

Related News

AOA-PAC election report: Optometry has outsized impact on 2024 elections

Tap into the AOA’s interactive 2024 elections map to see how hundreds of pro-optometry U.S. House and Senate candidates fared and learn how advocates can get more involved in the fight in our nation’s capital for patients and the future of the profession.

New AOA clinical guideline puts focus on elevating care of glaucoma patients

Guideline provides list of evidence- and consensus-based recommendations for care of primary open-angle glaucoma, the most common type of glaucoma. How many of these recommendations do you follow?

Introducing the new CMS G2211 code

In certain cases, this new code can be used for Medicare claims. Here’s how it works.